Privia Health Group (PRVA) to Release Earnings on Thursday

Privia Health Group (NASDAQ:PRVA) will be announcing its earnings results before the market opens on Thursday, November 7th. Analysts expect the company to announce earnings of $0.05 per share for the quarter. Privia Health Group has set its FY 2024 guidance at EPS.Parties that are interested in participating in the company’s conference call can do so using this link.

Privia Health Group (NASDAQ:PRVA) last posted its earnings results on Thursday, August 8th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.02). The business had revenue of $422.30 million during the quarter, compared to analyst estimates of $411.50 million. Privia Health Group had a net margin of 0.88% and a return on equity of 2.42%. Privia Health Group’s revenue was up 2.2% compared to the same quarter last year. During the same quarter last year, the firm earned $0.06 earnings per share. On average, analysts expect Privia Health Group to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Privia Health Group Price Performance

Privia Health Group stock opened at $19.22 on Tuesday. The company has a market capitalization of $2.30 billion, a price-to-earnings ratio of 160.17, a PEG ratio of 4.17 and a beta of 0.76. The company’s fifty day moving average price is $18.37 and its two-hundred day moving average price is $18.28. Privia Health Group has a one year low of $15.92 and a one year high of $24.35.

Insider Activity at Privia Health Group

In related news, CEO Parth Mehrotra sold 135,142 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total value of $2,500,127.00. Following the transaction, the chief executive officer now owns 247,771 shares of the company’s stock, valued at approximately $4,583,763.50. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 14.20% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several research firms recently weighed in on PRVA. Evercore ISI reduced their target price on shares of Privia Health Group from $23.00 to $20.00 and set an “outperform” rating for the company in a research note on Tuesday, July 9th. Royal Bank of Canada reissued an “outperform” rating and set a $28.00 price objective on shares of Privia Health Group in a report on Wednesday, August 14th. Robert W. Baird upped their target price on Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a research note on Monday, August 26th. Finally, KeyCorp initiated coverage on shares of Privia Health Group in a research note on Friday, October 11th. They set an “overweight” rating and a $23.00 price target on the stock. Two equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Privia Health Group presently has a consensus rating of “Buy” and a consensus price target of $24.73.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.